tiprankstipranks
Advertisement
Advertisement
P3 Health Partners Executes Debt Exchange to Bolster Equity
PremiumCompany AnnouncementsP3 Health Partners Executes Debt Exchange to Bolster Equity
15d ago
P3 Health Partners price target raised to $14 from $4 at Lake Street
Premium
The Fly
P3 Health Partners price target raised to $14 from $4 at Lake Street
15d ago
P3 Health Partners reports Q1 EPS 32c vs ($6.28) last year
Premium
The Fly
P3 Health Partners reports Q1 EPS 32c vs ($6.28) last year
16d ago
Maintaining Hold Amid Weak Near-Term Results but Potential Profitability by 2027 for P3
PremiumRatingsMaintaining Hold Amid Weak Near-Term Results but Potential Profitability by 2027 for P3
2M ago
Morning Movers: AstraZeneca jumps following tozorakimab trial results
Premium
The Fly
Morning Movers: AstraZeneca jumps following tozorakimab trial results
2M ago
P3 Health Partners price target lowered to $4 from $12.50 at Lake Street
Premium
The Fly
P3 Health Partners price target lowered to $4 from $12.50 at Lake Street
2M ago
Is PIII a Buy, Before Earnings?
PremiumPre-EarningsIs PIII a Buy, Before Earnings?
2M ago
P3 Health Partners Extends Availability of Growth Financing
Premium
Company Announcements
P3 Health Partners Extends Availability of Growth Financing
3M ago
P3 Health Partners Faces Nasdaq Compliance Challenge
Premium
Company Announcements
P3 Health Partners Faces Nasdaq Compliance Challenge
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100